Lab-made pancreas cells could free diabetics from insulin needles
NCT ID NCT07503028
First seen Apr 10, 2026 · Last updated Jun 19, 2026 · Updated 11 times
Summary
This early study tests a new treatment called CRG-002, made from stem cells that grow into insulin-producing cells. It is for people with type 1 or pancreatic diabetes who have dangerous low blood sugar episodes. The cells are placed into the body to help control blood sugar and may reduce or stop the need for insulin shots. The main goal is to check safety, but researchers will also see if it helps patients use less insulin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T1DM - TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Anhui Medicaluniversity
Hefei, Anhui, 230022, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.